S. Lawn, Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test, The Lancet Infectious Diseases, vol.13, issue.4, pp.349-61, 2013.
DOI : 10.1016/S1473-3099(13)70008-2

K. Steingart, H. Sohn, I. Schiller, L. Kloda, C. Boehme et al., Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults, Cochrane Database Syst Rev, vol.1, p.9593, 2013.

D. Antoine and C. D. , Les cas de tuberculose declares en France en 2010, Bull Epidémiol Hebd, pp.24-25, 2012.

K. Chang, W. Lu, J. Wang, K. Zhang, S. Jia et al., Rapid and effective diagnosis of tuberculosis and rifampicin resistance with Xpert MTB/RIF assay: A??meta-analysis, Journal of Infection, vol.64, issue.6, pp.580-588, 2012.
DOI : 10.1016/j.jinf.2012.02.012

H. Sohn, A. Aero, D. Menzies, M. Behr, K. Schwartzman et al., Xpert MTB/RIF Testing in a Low Tuberculosis Incidence, High-Resource Setting: Limitations in Accuracy and Clinical Impact, Clinical Infectious Diseases, vol.58, issue.7
DOI : 10.1093/cid/ciu022

C. Sreeramareddy, K. Panduru, J. Menten, and J. Van-den-ende, Time delays in diagnosis of pulmonary tuberculosis: a systematic review of literature, BMC Infectious Diseases, vol.9, issue.1, p.91, 2009.
DOI : 10.1371/journal.pone.0000757

D. Storla, S. Yimer, and G. Bjune, A systematic review of delay in the diagnosis and treatment of tuberculosis, BMC Public Health, vol.51, issue.10, p.15, 2008.
DOI : 10.1136/bmj.326.7395.909

M. Behr, S. Warren, and H. Salamon, Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli, The Lancet, vol.353, issue.9151, pp.444-453, 1999.
DOI : 10.1016/S0140-6736(98)03406-0

A. Tostmann, S. Kik, N. Kalisvaart, M. Sebek, S. Verver et al., Tuberculosis Transmission by Patients with Smear???Negative Pulmonary Tuberculosis in a Large Cohort in The Netherlands, Clinical Infectious Diseases, vol.47, issue.9, pp.1135-1142, 2008.
DOI : 10.1086/591974

F. Harrell, K. Lee, and D. Mark, MULTIVARIABLE PROGNOSTIC MODELS: ISSUES IN DEVELOPING MODELS, EVALUATING ASSUMPTIONS AND ADEQUACY, AND MEASURING AND REDUCING ERRORS, Statistics in Medicine, vol.15, issue.4, pp.361-387, 1996.
DOI : 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4

V. Elm, E. Altman, D. Egger, M. Pocock, S. Gøtzsche et al., Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies, BMJ, vol.335, issue.7624, pp.1453-1457
DOI : 10.1136/bmj.39335.541782.AD

O. Shea, M. Koh, G. Munang, M. Smith, G. Banerjee et al., Time-to-Detection in Culture Predicts Risk of Mycobacterium tuberculosis Transmission: A Cohort Study, Clinical Infectious Diseases, vol.59, issue.2, pp.177-185, 2014.
DOI : 10.1093/cid/ciu244

C. Bark, P. Gitta, and S. Ogwang, Comparison of time to positive and colony counting in an early bactericidal activity study of anti-tuberculosis treatment, The International Journal of Tuberculosis and Lung Disease, vol.17, issue.11, pp.1448-51, 2013.
DOI : 10.5588/ijtld.13.0063

A. Odone, R. Houben, R. White, and K. Lönnroth, The effect of diabetes and undernutrition trends on reaching 2035 global tuberculosis targets, The Lancet Diabetes & Endocrinology, vol.2, issue.9, pp.754-64, 2014.
DOI : 10.1016/S2213-8587(14)70164-0

B. Adamu, A. Abdu, A. Abba, M. Borodo, and I. Tleyjeh, Antibiotic prophylaxis for preventing post solid organ transplant tuberculosis, Cochrane Database Syst Rev, vol.3, p.8597, 2014.

J. Askling, C. Fored, L. Brandt, E. Baecklund, L. Bertilsson et al., Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden, Arthritis & Rheumatism, vol.63, issue.7, pp.1986-92, 2005.
DOI : 10.1002/art.21137

W. Dixon, K. Watson, M. Lunt, K. Hyrich, A. Silman et al., Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti???tumor necrosis factor therapy: Results from the British Society for Rheumatology Biologics Register, Arthritis & Rheumatism, vol.50, issue.8, pp.2368-76, 2006.
DOI : 10.1002/art.21978

J. Gomez-reino, L. Carmona, V. Valverde, E. Mola, and M. Montero, Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: A multicenter active-surveillance report, Arthritis & Rheumatism, vol.44, issue.Suppl 9, pp.2122-2129, 2003.
DOI : 10.1002/art.11137

J. Keane, G. S. Wise, R. Mirabile-levens, E. Kasznica, J. Schwieterman et al., Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor ?????Neutralizing Agent, New England Journal of Medicine, vol.345, issue.15, pp.1098-104, 2001.
DOI : 10.1056/NEJMoa011110

P. Tattevin, E. Casalino, L. Fleury, G. Egmann, M. Ruel et al., The Validity of Medical History, Classic Symptoms, and Chest Radiographs in Predicting Pulmonary Tuberculosis, Chest, vol.115, issue.5, pp.1248-53, 1999.
DOI : 10.1378/chest.115.5.1248

M. Lagrange-xélot, R. Porcher, S. Gallien, A. Wargnier, J. Pavie et al., Prevalence and clinical predictors of pulmonary tuberculosis among isolated inpatients: a prospective study, Clinical Microbiology and Infection, vol.17, issue.4
DOI : 10.1111/j.1469-0691.2010.03259.x

A. Kanaya, D. Glidden, and H. Chambers, Identifying Pulmonary Tuberculosis in Patients With Negative Sputum Smear Results, Chest, vol.120, issue.2, pp.349-55, 2001.
DOI : 10.1378/chest.120.2.349

M. Iademarco, Availability of an assay for detecting Mycobacterium tuberculosis, including rifampin-resistant strains, and considerations for its use?United States, 2013, MMWR Morb Mortal Wkly Rep, vol.62, pp.821-825, 2013.

H. Choi, K. Miele, D. Dowdy, and M. Shah, Cost-effectiveness of Xpert?? MTB/RIF for diagnosing pulmonary tuberculosis in the United States, The International Journal of Tuberculosis and Lung Disease, vol.17, issue.10, pp.1328-1335, 2013.
DOI : 10.5588/ijtld.13.0095

L. Solari, C. Acuna-villaorduna, A. Soto, and P. Van-der-stuyft, Evaluation of Clinical Prediction Rules for Respiratory Isolation of Inpatients with Suspected Pulmonary Tuberculosis, Clinical Infectious Diseases, vol.52, issue.5, pp.595-603, 2011.
DOI : 10.1093/cid/ciq186

J. Mylotte, J. Rodgers, M. Fassl, K. Seibel, and A. Vacanti, Derivation and Validation of a Pulmonary Tuberculosis Prediction Model, Infection Control and Hospital Epidemiology, vol.18, issue.8, pp.554-60, 1997.
DOI : 10.2307/30141265

J. Wisnivesky, J. Kaplan, C. Henschke, T. Mcginn, and R. Crystal, Evaluation of Clinical Parameters to Predict Mycobacterium tuberculosis in Inpatients, Archives of Internal Medicine, vol.160, issue.16, pp.2471-2477, 2000.
DOI : 10.1001/archinte.160.16.2471

C. Wejse, P. Gustafson, J. Nielsen, V. Gomes, P. Aaby et al., TBscore: Signs and symptoms from tuberculosis patients in a low-resource setting have predictive value and may be used to assess clinical course, Scandinavian Journal of Infectious Diseases, vol.8, issue.2, pp.111-131, 2008.
DOI : 10.1001/archinte.158.17.1870

F. Rudolf, G. Lemvik, E. Abate, J. Verkuilen, T. Schön et al., TBscore II: Refining and validating a simple clinical score for treatment monitoring of patients with pulmonary tuberculosis, Scandinavian Journal of Infectious Diseases, vol.11, issue.6, pp.825-861, 2013.
DOI : 10.1001/jama.1997.03540300056034

F. Mello, L. Bastos, S. Soares, V. Rezende, M. Conde et al., Predicting smear negative pulmonary tuberculosis with classification trees and logistic regression: a cross-sectional study, BMC Public Health, vol.70, issue.1, p.43, 2006.
DOI : 10.1001/jama.283.5.639

C. Etude-cas-témoins-monocentrique-un and . Parisien, Les cas avaient une p-TB suspectée puis confirmée, les témoins avaient une TB suspectée puis infirmée. Les patients immunodéprimés n'ont pas été inclus Appariement 1:1 sur l'année et le service d'hospitalisation. Modèle de régression logistique conditionnelle. Score construit à partir des coefficients du modèle multivarié. La discrimination (C-index), la calibration (test de Hosmer-Lemeshow) et la validité interne ont été évaluées, Analyse de sensibilité: calibration du modèle chez les cas avec examen direct négatif, 2009.